GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB BioStep Co Ltd (XKRX:278650) » Definitions » Cyclically Adjusted FCF per Share

HLB BioStep Co (XKRX:278650) Cyclically Adjusted FCF per Share : ₩-69.29 (As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is HLB BioStep Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

HLB BioStep Co's adjusted free cash flow per share data for the fiscal year that ended in Dec. 2024 was ₩-240.497. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ₩-69.29 for the trailing ten years ended in Dec. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2025-06-01), HLB BioStep Co's current stock price is ₩ 1570.00. HLB BioStep Co's Cyclically Adjusted FCF per Share for the fiscal year that ended in Dec. 2024 was ₩-69.29. HLB BioStep Co's Cyclically Adjusted Price-to-FCF of today is .


HLB BioStep Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for HLB BioStep Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB BioStep Co Cyclically Adjusted FCF per Share Chart

HLB BioStep Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -69.29

HLB BioStep Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -69.29 -

Competitive Comparison of HLB BioStep Co's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, HLB BioStep Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HLB BioStep Co's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HLB BioStep Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where HLB BioStep Co's Cyclically Adjusted Price-to-FCF falls into.


;
;

HLB BioStep Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, HLB BioStep Co's adjusted Free Cash Flow per Share data for the fiscal year that ended in Dec. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-240.497/121.1352*121.1352
=-240.497

Current CPI (Dec. 2024) = 121.1352.

HLB BioStep Co Annual Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201512 -2,261.928 100.220 -2,733.965
201612 1,582.090 101.561 1,887.006
201712 517.217 102.991 608.338
201812 -171.176 104.351 -198.709
201912 -7.273 105.121 -8.381
202012 100.334 105.765 114.915
202112 -129.011 109.676 -142.490
202212 5.857 115.179 6.160
202312 14.459 118.837 14.739
202412 -240.497 121.135 -240.497

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


HLB BioStep Co  (XKRX:278650) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


HLB BioStep Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of HLB BioStep Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


HLB BioStep Co Business Description

Industry
Traded in Other Exchanges
N/A
Address
38, Academy-ro 79beon-gil, Yeonsu-gu, Incheon, KOR, 22014
HLB BioStep Co Ltd provides non-clinical services necessary for leading domestic and foreign pharmaceutical companies and bio ventures in the process of developing drugs and health functional foods.

HLB BioStep Co Headlines

No Headlines